{
  "submitter" : "Reach",
  "model_relation" : "extension",
  "extracted_information" : {
    "interaction_type" : "binds",
    "negative_information" : false,
    "participant_b" : {
      "in_model" : true,
      "identifier" : "pubchem:5394",
      "entity_text" : "TMZ",
      "entity_type" : "simple_chemical"
    },
    "participant_a" : {
      "in_model" : true,
      "identifier" : "uniprot:O75874",
      "entity_text" : "IDH",
      "features" : [ {
        "to_base" : "A",
        "site" : 0,
        "feature_type" : "mutation",
        "evidence" : "mutation"
      } ],
      "entity_type" : "protein"
    },
    "hypothesis_information" : true,
    "context" : {
      "CellLine" : [ "uaz:UA-CLine-5317" ],
      "Species" : [ "taxonomy:9606" ],
      "TissueType" : [ "tissuelist:TS-0150" ]
    }
  },
  "verbose_text" : "Although classification has been established on the basis of IDH status among GBM, some studies indicated that IDH mutation, MGMT promoter methylation status, 1p/19q loss independently associated with favorable outcome in temozolomide (TMZ) + radiotherapy treated GBM patients.",
  "reading_complete" : "2020-08-02T16:55:58Z",
  "reader_type" : "machine",
  "reading_started" : "2020-08-02T16:52:29Z",
  "trigger" : "associated",
  "evidence" : [ "IDH mutation, MGMT promoter methylation status, 1p/19q loss independently associated with favorable outcome in temozolomide (TMZ" ],
  "pmc_id" : "5062843",
  "score" : 0
}